The UAE Goverment has announced that it’s launching the world’s first phase III clinical trials of a Covid-19 vaccine.
If successful, the Covid-19 vaccine could be available to the public by the end of 2020 or in the early part of 2021 according to WAM, the UAE’s news agency.
The vaccine is a joint collaboration between a Chinese company and Abu Dhabi’s Group 42. The clinical trials will be held in the UAE and will be monitored by the Department of Health (DoH) Abu Dhabi.
#UAE launches world's first phase III clinical trial of inactivated #COVID19 vaccine#WamNews https://t.co/kifcLSp6B6 pic.twitter.com/InpxLc4uuh— WAM English (@WAMNEWS_ENG) June 23, 2020
#UAE launches world's first phase III clinical trial of inactivated #COVID19 vaccine#WamNews https://t.co/kifcLSp6B6 pic.twitter.com/InpxLc4uuh
As anyone who’s been following the pandemic knows by now, launching a vaccine is a long process. The first phase looks at the safety of the vaccine while the second stage looks at how effective it is.
The third phase studies how safe and effective the vaccine is for a large population. This is generally the last stage of the process. And if successful, it can then be taken to market.
The Covid-19 vaccine in the UAE has so far had a 100 per cent success rate, with all the volunteers creating antibodies after two doses in 28 days.
The UK meanwhile has made progress in treating Coronavirus symptoms.
Dexamethasone is being tested as part of the world’s biggest trial treatments. And it’s had impressive results so far.
In studies so far, it cuts the risk of death by a third for patients on ventilators. And it reduces the risk of death by a fifth for those on oxygen.
The low-dose steroid is relatively cheap and easy to make. And the drug could make a life-saving difference to Coronavirus patients around the world.
The UK has is ordering 200,000 doses for the NHS. And they believe it could make a huge impact on the Coronavirus pandemic.